Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001493152-18-011715
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$1.26M | $1.02M | -$4.70M | -$890.80K |
| EPS Diluted | -$0.29 | $0.25 | -$0.13 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end
